Clinical trial
Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids
NCT00205712 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00205712 |
|---|---|
| Title | Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids |
| Official title | Prevention of NMDA Antagonist-induced Psychosis and Memory Impairment in Children |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Psychoses, Substance-Induced |
| Intervention type | Drug |
| Interventions | Ketamine, Dexmedetomidine |
| Enrollment | 40 |
| Start date | Feb 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: